KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Cash & Current Investments (2016 - 2026)

West Pharmaceutical Services has reported Cash & Current Investments over the past 18 years, most recently at $521.4 million for Q1 2026.

  • Quarterly Cash & Current Investments rose 29.0% to $521.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $521.4 million through Mar 2026, up 29.0% year-over-year, with the annual reading at $791.3 million for FY2025, 63.29% up from the prior year.
  • Cash & Current Investments was $521.4 million for Q1 2026 at West Pharmaceutical Services, down from $791.3 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $898.6 million in Q3 2023 and troughed at $404.2 million in Q1 2025.
  • The 5-year median for Cash & Current Investments is $667.7 million (2022), against an average of $666.1 million.
  • Biggest five-year swings in Cash & Current Investments: plummeted 45.37% in 2024 and later surged 63.29% in 2025.
  • Tracing WST's Cash & Current Investments over 5 years: stood at $894.3 million in 2022, then fell by 4.52% to $853.9 million in 2023, then plummeted by 43.25% to $484.6 million in 2024, then surged by 63.29% to $791.3 million in 2025, then plummeted by 34.11% to $521.4 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $521.4 million, $791.3 million, and $628.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.